Results 11 to 20 of about 354,756 (297)

Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum [PDF]

Journal of Thrombosis and Thrombolysis, 2020
Coronavirus disease 2019 (COVID-19) is a viral infection that can, in severe cases, result in cytokine storm, systemic inflammatory response and coagulopathy that is prognostic of poor outcomes. While some, but not all, laboratory findings appear similar
Geoffrey D. Barnes, Allison Burnett, Arthur L. Allen, Marilyn Blumenstein, Nathan P. Clark, Adam Cuker, William E. Dager, Steven Deitelzweig, Stacy Ellsworth, David García, Scott Kaatz, Tracy Minichiello   +11 more
openalex   +2 more sources

Endoscopy in patients on antiplatelet or anticoagulant therapy: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guideline update

Gut, 2021
This is a collaboration between the British Society of Gastroenterology (BSG) and the European Society of Gastrointestinal Endoscopy (ESGE), and is a scheduled update of their 2016 guideline on endoscopy in patients on antiplatelet or anticoagulant ...
A. Veitch, F. Radaelli, R. Alikhan, J. Dumonceau, D. Eaton, J. Jerrome, W. Lester, D. Nylander, Mo Thoufeeq, G. Vanbiervliet, J. Wilkinson, J. V. van Hooft   +11 more
semanticscholar   +1 more source

Geriatric Elements and Oral Anticoagulant Prescribing in Older Atrial Fibrillation Patients: SAGE‐AF [PDF]

Journal of The American Geriatrics Society, 2019
Oral anticoagulants are the cornerstone of stroke prevention in high‐risk patients with atrial fibrillation (AF). Geriatric elements, such as cognitive impairment and frailty, commonly occur in these patients and are often cited as reasons for not ...
Jane S. Saczynski, Saket Sanghai, Catarina I. Kiefe, Darleen Lessard, Francesca Marino, Molly E. Waring, David C. Parish, Robert Helm, Felix Sogade, Robert J. Goldberg, Jerry H. Gurwitz, Weijia Wang, Tanya Mailhot, Benita A. Bamgbade, Bruce Barton, David D. McManus   +15 more
openalex   +2 more sources

A thrombin-triggered self-regulating anticoagulant strategy combined with anti-inflammatory capacity for blood-contacting implants

Science Advances, 2022
Interrelated coagulation and inflammation are impediments to endothelialization, a prerequisite for the long-term function of cardiovascular materials.
Yanan Wang, Haoshuang Wu, Zhong Zhou, M. Maitz, Kun Liu, Bo Zhang, Li Yang, Rifang Luo, Yunbing Wang   +8 more
semanticscholar   +1 more source

Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy

Journal of Thrombosis and Haemostasis, 2020
A relatively high mortality of severe coronavirus disease 2019 (COVID‐19) is worrying, and the application of heparin in COVID‐19 has been recommended by some expert consensus because of the risk of disseminated intravascular coagulation and venous ...
N. Tang, Huan Bai, Xing Chen, Jiale Gong, Dengju Li, Ziyong Sun   +5 more
semanticscholar   +1 more source

Direct Oral Anticoagulant Use: A Practical Guide to Common Clinical Challenges

Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease, 2020
Direct oral anticoagulants (DOACs) have quickly become attractive alternatives to the long‐standing standard of care in anticoagulation, vitamin K antagonist. DOACs are indicated for prevention and treatment of several cardiovascular conditions.
Ashley Chen, E. Stecker, Bruce A Warden
semanticscholar   +1 more source

Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19

New England Journal of Medicine, 2020
Prolonged aPTT in Patients with Covid-19 In this study, 20% of patients with Covid-19 had a prolonged activated partial-thromboplastin time.
L. Bowles, S. Platton, Nada Yartey, Minal Dave, Kurtis Lee, D. Hart, Vickie MacDonald, Laura Green, S. Sivapalaratnam, K. Pasi, P. Maccallum   +10 more
semanticscholar   +1 more source

Drug Interactions Affecting Oral Anticoagulant Use

Circulation: Arrhythmia and Electrophysiology, 2022
Oral anticoagulants (OACs) are medications commonly used in patients with atrial fibrillation and other cardiovascular conditions. Both warfarin and direct oral anticoagulants are susceptible to drug-drug interactions (DDIs).
Philip L. Mar, R. Gopinathannair, Brooke E. Gengler, M. Chung, Arturo Perez, J. Dukes, M. Ezekowitz, Dhanunjaya Lakkireddy, G. Lip, Mike Miletello, P. Noseworthy, J. Reiffel, J. Tisdale, B. Olshansky   +13 more
semanticscholar   +1 more source

Guidance from the Scientific and Standardization Committee for lupus anticoagulant/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis

Journal of Thrombosis and Haemostasis, 2020
This guidance focuses on methodological aspects of lupus anticoagulant (LA) testing, as well as interpretation of results for clinicians. The main changes in how to test for LA compared with the International Society on Thrombosis and Haemostasis ...
K. Devreese, P. D. de Groot, B. de Laat, D. Erkan, E. Favaloro, I. Mackie, M. Martinuzzo, T. Ortel, V. Pengo, J. Rand, A. Tripodi, D. Wahl, H. Cohen   +12 more
semanticscholar   +1 more source

Lupus anticoagulant is frequent in patients with Covid‐19

Journal of Thrombosis and Haemostasis, 2020
Patients hospitalized for Covid-19 severe infection are more prone to excessive coagulation activation leading to thrombotic events. Tang et al.1 discussed the importance of high D-dimer and Fibrin degradation product level to determine the patient ...
I. Harzallah, A. Debliquis, B. Drénou
semanticscholar   +1 more source